期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

卵巢癌耐药相关微小RNA的研究进展 被引量：1

Advances in the research of microRNA associated drug resistance in ovarian cancer
原文传递
导出
摘要 越来越多的证据表明，微小RNA（miRNA）的异常表达与肿瘤发生发展、转移及预后等密切相关。最近研究发现，异常表达的miRNA与卵巢癌化疗抵抗相关，提示miRNA将可能成为卵巢癌治疗的新靶点。进一步阐明miRNA与卵巢癌耐药的相关机制将有利于miRNA靶向治疗的研究。 Evidence is accumulating that aberrant microRNA （miRNA） expression contributes to the development and metastasis of cancer. Emerging evidence demonstrates that miRNA plays an important role in drug resistance in ovarian cancer and that it may become a new therapeutic target. It is important to further elu- cidate the mechanisms of miRNA associated drug resistance in ovarian cancer.
作者 吴秋华(综述) 王沂峰(审校)
机构地区 广州医学院第三附属医院妇产科
出处 《国际肿瘤学杂志》 CAS 2010年第10期780-782,共3页 Journal of International Oncology
基金 基金项目：广东省自然科学基金资助项目（7002691）
关键词 MICRORNA 卵巢肿瘤 抗药性 顺铂 MicroRNA Ovarian neoplasms Drug resistance Cisplatin
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献21

  • 1Jemal A,Murray T,Ward E,et al.Cancer statistics.CA Cancer J Clin,2005,55(1):10-30.
  • 2Sorrentino A,Liu CG,Addario A,et al.Role of microRNAs in drugresistant ovarian cancer cells.Gynecol Oncol,2008,111(3):478-486.
  • 3Eitan R,Kushnir M,Lithwick-Yanai G,et al.Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.Gynecol Oncol,2009,114(2):253-259.
  • 4Boren T,Xiong Y,Hakam A,et al.MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.Gynecol Oncol,2009,113(2):249-255.
  • 5Zhu H,Wu H,Liu X,et al.Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.Biochem Pharmacol,2008,76(5):582-588.
  • 6Wu H,Wang S,Weng D,et al.Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene.Cancer Lett,2008,271(2):205-214.
  • 7Yang H,Kong W,He L,et al.MicroRNA expression profiling in human ovarian cancer:miR-214 induces cell survival and cisplatin resistance by targeting PTEN.Cancer Res,2008,68(2):425-433.
  • 8Nagaraja AK,Creighton CJ,Yu Z,et al.A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.Mol Endocrinol,2010,24(2):447-463.
  • 9Guo LM,Pu Y,Han Z,et al.MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.FEBS J,2009,27(19):5537-5546.
  • 10Chen R,Alvero AB,Silasi DA,et al.Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells.Oncogene,2008,27(34):4712-4723.

同被引文献20

引证文献1

二级引证文献3

国际肿瘤学杂志
2010年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部